Quality of life assessment in chronic skin disorders

Authors

  • Amer Ejaz
  • Sajid Ejaz Rao
  • Amir Manzoor
  • Amber Niaz

Keywords:

Skin diseases, dermatology life quality index, impact on quality of life

Abstract

Objective To assess the impact of disease on quality of life of dermatological patients by using dermatology life quality index (DLQI).Methods One hundred consecutive adult patients with any dermatological disease lasting more than six months were interviewed and filled DLQI questionnaire. DLQI is a broad, self-administered, dermatology specific questionnaire that measures the impact of skin diseases on health-related quality of life in patients. It covers six domains (symptoms, feelings, routine daily activities, sports activities, work and school, personal relationships, and treatment) during the preceding one week. In our study, both original English and validated Urdu versions of the instrument were used for patients in either language of ease.Results There were 58 males and 42 females. Mean age was 42+17 years. A total of 26 dermatological diseases were found in our patients. Chronic eczema was the commonest diagnosis in 29% of patients, followed by melasma in 11%. The duration of illness varied from 6 months to 25 years whereas mean duration was 10.48+5.9 years. DLQI score varied from 0-20, mean score was 10.02+4.09. Score was significantly associated with disease duration (p value 0.0001, student t test).  The difference in DLQI scores between sexes was not significant (p value0.32, student t test).Conclusion Skin diseases, irrespective of the diagnosis, impair quality of life which is directly proportional to the duration of disease. 

References

Potocka A, Turczyn-Jabłońska K, Kieć-Swierczyńska M. Self-image and quality of life of dermatology patients. Int J Occup Med Environ Health. 2008;21:309-17.

Manzoni APDS, Townsend RZ, Weber MB et al. Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases. An Bras Dermatol. 2012;87:361-8.

Finlay AY. Skin disease disability: Measuring its magnitude. Keio J Med. 1998;47:131-4.

Finlay AY. Quality of life indices. Indian J Dermatol Venereol Leprol. 2004;70:143-8.

Dogar IA, Haider N, Naseem S et al. Comparison of quality of life among cardiac, hepatic, cancer, and dermatological patients. J Pak Med Assoc. 2012;62:232-5.

Asad F, Qadir A, Nadeem M. Quality of life in patients with acne vulgaris. J Coll Physicians Surg Pak. 2002;12:654-6.

Aman S, Akbar TM, Hussain I et al. The effect of itraconazole pulse therapy on quality of life in Pakistani patients of distolateral subungual onychomycosis. J Pak Assoc Dermatol. 2004;14:198-204.

Shaukat S, Aman S, Hussain I, Kazmi AH. The effect of oral doxycycline and topical 5% benzoyl peroxide on quality of life in patients with mild to moderate acne vulgaris. J Pak Assoc Dermatol. 2013;23:173-9.

Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI—a simple practical measure for routine clinical use). Clin Exp Dermatol. 1994;19:210-6.

Lewis V, Finlay A. 10 Years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9:169-80.

Ghajarzadeh M, Ghiasi M, Kheirkhah S. Associations between skin diseases and quality of life: A comparison of psoriasis, vitiligo, and alopecia areata. Acta Medica Iranica. 2012;50:511-5.

Downloads

Published

2016-11-19

How to Cite

1.
Ejaz A, Rao SE, Manzoor A, Niaz A. Quality of life assessment in chronic skin disorders. J Pak Assoc Dermatol [Internet]. 2016Nov.19 [cited 2024Dec.7];25(2):86-9. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/87

Issue

Section

Original Articles